go back

Ranibizumab (Susvimo) Sustained-Release Implant

Nevada rates for HCPCS C9093

Injection, ranibizumab, via sustained release intravitreal implant (Susvimo), 0.1 mg

Rates data updated October 2026.

How much rates vary

Facilitymedian $79 · 10th to 90th $79 to $79Professionalmedian $81 · 10th to 90th $79 to $95
$100facility $79professional $81

Distribution of negotiated rates across all payers (price axis is log-scale). Small sample; interpret with caution. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Aetna
Setting
Facility
Modifier
None
Typical Low
$79.43
Median
$79.43
Typical High
$79.43
Aetna
Setting
Professional
Modifier
None
Typical Low
$66.07
Median
$79.43
Typical High
$81.28
United
Setting
Professional
Modifier
None
Typical Low
$95.50
Median
$95.50
Typical High
$95.50